Bay Street News, February 20th, 2020

CAMBRIDGE, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, […]

BRISBANE, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK), today announced that it will report fourth quarter […]

WOODCLIFF LAKE, N.J., Feb. 20, 2020 (GLOBE NEWSWIRE) — PowerFleet, Inc. (NASDAQ: PWFL), a global leader and provider of subscription-based […]

TEMPLE CITY, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) — Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today […]

SOUTH SAN FRANCISCO, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company […]

SOUTH SAN FRANCISCO, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it […]

4Q Net Loss of $410.2 Million Reflects Noncash Special Charge of $485.2 Million4Q Adjusted EBITDA Totals $204.7 Million, Adjusted Net […]

RICHMOND, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) — Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology […]

HOLLYWOOD, Fla., Feb. 20, 2020 (GLOBE NEWSWIRE) — NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of […]

ATLANTA, Feb. 20, 2020 (GLOBE NEWSWIRE) — The Providence Service Corporation (the “Company” or “Providence”) (Nasdaq: PRSC) is scheduled to […]